Severine Garnier
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
A standardized approach to test missense PNPLA1 rare genetic variants of uncertain significance in epidermal differentiation disorders.
Journal: JID innovations : skin science from molecules to population health
Published: August 14, 2025
Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial.
Journal: Frontiers in oncology
Published: May 17, 2022
Overcoming Resistance to Anti-Nectin-4 Antibody-Drug Conjugate.
Journal: Molecular cancer therapeutics
Published: January 06, 2022
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
Journal: Molecular oncology
Published: November 30, 2021
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 14, 2021
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.
Journal: Blood cancer journal
Published: December 26, 2019
Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B.
Journal: JCO precision oncology
Published: December 01, 2019
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Journal: Molecular oncology
Published: November 13, 2019
Last Updated: 09/26/2026